Overview

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

Status:
Completed
Trial end date:
2008-03-06
Target enrollment:
Participant gender:
Summary
This study intends to demonstrate bioequivalence and lack of food effect on 250mg lamotrigine XR in healthy male and female volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine